Dr. Dean Regier is a Senior Scientist at the BC Cancer Research Institute, Associate Professor at UBC’s School of Population and Public Health, and Director of the Academy of Translational Medicine. An internationally recognized health economist, he specializes in translational medicine and regulatory science, with research focused on learning healthcare systems, patient-oriented outcomes, and generating real-world evidence from NLP-curated data and machine learning. His work has advanced equitable access to genomic technologies in Canada and internationally, particularly in precision oncology and rare diseases. Dr. Regier developed Canada’s first micro-certificate program in regulatory affairs and regulatory science, and chairs UBC’s Faculty of Medicine Regulatory Advisory Council to support researchers navigating complex regulatory pathways. He previously served on B.C.’s Drug Benefit Council, providing evidence-based recommendations on public drug coverage.
Year 2024
Type Match Funding
Partner(s) 
Genome BC, Terry Fox Research Institute